24 results on '"Feringa, Harm H."'
Search Results
2. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery
- Author
-
Feringa, Harm H H, Schouten, Olaf, Dunkelgrun, Martin, Bax, Jeroen J, Boersma, Eric, Elhendy, Abdou, de Jonge, Robert, Karagiannis, Stefanos E, Vidakovic, Radosav, and Poldermans, Don
- Published
- 2007
3. Statins for the prevention of perioperative cardiovascular complications in vascular surgery
- Author
-
Schouten, Olaf, Bax, Jeroen J., Dunkelgrun, Martin, Feringa, Harm H., van Urk, Hero, and Poldermans, Don
- Published
- 2006
4. Regarding “Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial”
- Author
-
Schouten, Olaf, van Urk, Hero, Feringa, Harm H. H., Bax, Jeroen J., and Poldermans, Don
- Published
- 2005
5. Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging
- Author
-
Elhendy, Abdou, Schinkel, Arend F.L., Van Domburg, Ron T., Bax, Jeroen J., Valkema, Roelf, Huurman, Aukje, Feringa, Harm H., Poldermans, Don, Elhendy, Abdou, Schinkel, Arend F.L., Van Domburg, Ron T., Bax, Jeroen J., Valkema, Roelf, Huurman, Aukje, Feringa, Harm H., and Poldermans, Don
- Abstract
Angina pectoris is a major symptom associated with myocardial ischemia. The aim of this study was to find whether stress myocardial perfusion imaging can independently predict mortality in patients with angina. Methods: We studied 455 patients with stable angina pectoris by exercise or dobutamine stress 99mTc-tetrofosmin myocardial perfusion tomographic imaging. An abnormal finding was defined as a reversible or fixed perfusion abnormality. The endpoint during follow-up was death from any cause. Results: Mean age was 60 ± 10 y. There were 266 men (58% of the patients). Myocardial perfusion was normal in 137 patients (30%). Perfusion abnormalities were reversible in 167 patients and fixed in 151 patients. During a mean follow-up of 6 ± 1.7 y, 93 patients (20%) died. The annual mortality rate was 1.5% in patients with normal perfusion and 4.5% in patients with abnormal perfusion. Patients with a multivessel distribution of perfusion abnormalities had a higher annual death rate than patients with abnormalities in a single-vessel distribution (5.1% vs. 3.7%). In a multivariate analysis model, independent predictors of death were age (risk ratio, 1.05; 95% confidence interval [CI], 1.03-1.08), the male sex (risk ratio, 2.1; CI, 1.3-3.4), diabetes (risk ratio, 2.2; CI, 1.4-3.5), heart failure (risk ratio, 2.7; CI, 1.6-4.5), smoking (risk ratio, 1.7; CI, 1.1-2.6), reversible perfusion abnormalities (risk ratio, 1.9; CI, 1.1-2.8), and fixed perfusion abnormalities (risk ratio, 2; CI, 1.2-3.1). Conclusion: Stress 99mTc-tetrofosmin myocardial perfusion imaging provides independent information for predicting mortality in patients with stable angina pectoris. Both reversible and fixed defects are associated with an increased risk of death. The extent of stress perfusion abnormalities is a major determinant of mortality. Patients with normal perfusion have a low mortality rate during long-term follow-up.
- Published
- 2005
6. Abstract 5789: Prevention of Peripheral Arterial Disease With Calcium Channel Blockers in Patients With Hypertension: A Meta-analysis of Randomized Trials
- Author
-
Feringa, Harm H, primary, Emani, Usha R, additional, Ardestani, Afrooz, additional, Shetty, Shilpa, additional, and Pearson, William N, additional
- Published
- 2009
- Full Text
- View/download PDF
7. Perioperative β-Blockade: Still Not Enough for Adequate Cardioprotection!
- Author
-
Schouten, Olaf, primary, Fleisher, Lee A., additional, London, Martin J., additional, Feringa, Harm H. H., additional, Bax, Jeroen J., additional, and Poldermans, Don, additional
- Published
- 2007
- Full Text
- View/download PDF
8. Abstract 4197: Statins and ACE-Inhibitors Prevent Renal Deterioration in Patients with Peripheral Arterial Disease
- Author
-
Feringa, Harm H, primary, Welten, Gijs, additional, Hoeks, Sanne, additional, Dunkelgrun, Martin, additional, Azizi, Fahim, additional, van Gestel, Yvette, additional, Vidakovic, Radosav, additional, Schouten, Olaf, additional, van Domburg, Ron, additional, de Liefde, Inge, additional, Karagiannis, Stefanos, additional, and Poldermans, Don, additional
- Published
- 2006
- Full Text
- View/download PDF
9. Risk Stratification of Patients with Angina Pectoris by Stress 99mTc-Tetrofosmin Myocardial Perfusion Imaging.
- Author
-
Elhendy, Abdou, Schinkel, Arend F. L., van Domburg, Ron T., Bax, Jeroen J., Valkema, Roelf, Huurman, Aukje, Feringa, Harm H., and Poldermans, Don
- Published
- 2005
10. Echocardiographic Screening Results in Patients with Tuberous Sclerosis Complex.
- Author
-
Adriaensen, Miraude E. A. P. M., Cramer, Maarten J. M., Brouha, Madelon E. E., Schaefer-Prokop, Cornelia M., Prokop, Mathias, Doevendans, Pieter A. F. M., Zonnenberg, Bernard A., and Feringa, Harm H. H.
- Subjects
- *
ECHOCARDIOGRAPHY , *TUBEROUS sclerosis , *HEMANGIOMAS , *TUMORS , *ULTRASONIC imaging , *DISEASE complications - Abstract
We sought to examine the frequency of abnormal echocardiographic findings in patients with tuberous sclerosis complex. In a retrospective cohort study, we included all patients with known tuberous sclerosis complex who had been sent to our cardiology department for echocardiographic screening from 1995 through August 2003 (n=56). Two research scientists independently reviewed the reports of the echocardiographic screening examinations for abnormal findings. We used descriptive statistics, the Mann-Whitney U test, and the χ² test. The mean age of patients included in the study was 35 years (range, 12-73 yr); 23 patients were male. Abnormal findings were seen in 22 patients (39%). The most common abnormal findings were focal areas of increased intramyocardial echogenicity, which were seen in 16 patients (29%). The clinical consequence of this finding is still unknown. We conclude that echocardiographic abnormalities are common in patients with tuberous sclerosis complex. [ABSTRACT FROM AUTHOR]
- Published
- 2010
11. Statistical models and patient predictors of readmission for acute myocardial infarction: a systematic review.
- Author
-
Desai MM, Stauffer BD, Feringa HH, and Schreiner GC
- Subjects
- Humans, Predictive Value of Tests, Evidence-Based Medicine statistics & numerical data, Models, Statistical, Myocardial Infarction epidemiology, Patient Readmission statistics & numerical data
- Abstract
Background: Readmission after acute myocardial infarction (AMI) has been targeted for public reporting because it is a common, costly, and often preventable outcome. To assist in ongoing efforts to risk-stratify patients and profile hospitals through public reporting of performance measures, we conducted a systematic review to identify models designed to compare hospital rates of readmission or predict patients' risk of readmission after AMI and to identify studies evaluating patient characteristics associated with AMI readmission., Methods and Results: We identified relevant English-language studies published between 1950 and 2007 by searching MEDLINE, Scopus, PsycINFO, and all 4 Ovid Evidence-Based Medicine Reviews. Eligible publications reported on readmission up to 1 year after AMI hospitalization among adults. From 751 potentially relevant articles, 35 met our predefined inclusion/exclusion criteria. Overall, none developed models to compare readmission rates among hospitals or models to predict patients' risk of readmission. All 35 examined patient characteristics associated with AMI readmission. However, studies varied in methods for case and outcome identification, used multiple types of data sources, examined differing outcomes (often either readmission alone or a composite outcome of readmission or death) over varying follow-up periods (from 30 days to 1 year), and found few patient characteristics consistently associated with readmission., Conclusions: Patient characteristics may be important predictors of AMI readmission; however, few variables were consistently identified. Thus, clinically, patient risk stratification is challenging. From a policy perspective, a validated risk-standardized model to profile hospitals using AMI readmission rates is currently unavailable in the literature.
- Published
- 2009
- Full Text
- View/download PDF
12. Early and late outcome of left ventricular reconstruction surgery in ischemic heart disease.
- Author
-
Klein P, Bax JJ, Shaw LJ, Feringa HH, Versteegh MI, Dion RA, and Klautz RJ
- Subjects
- Coronary Artery Bypass mortality, Follow-Up Studies, Heart Valve Prosthesis Implantation mortality, Heart Ventricles surgery, Hospital Mortality, Humans, Mitral Valve, Postoperative Complications mortality, Risk, Survival Rate, Time Factors, Myocardial Ischemia mortality, Myocardial Ischemia surgery
- Abstract
A systematic review of the literature was performed to determine early and late mortality associated with left ventricular (LV) reconstruction surgery and to assess the influence of different surgical techniques, concomitant surgical procedures, clinical and hemodynamic parameters on mortality. The MEDLINE database (January 1980-January 2005) was searched and from the pooled data, hospital mortality and survival were calculated. Summary estimates of relative risks (RR) were calculated for the techniques that were used and for concomitant coronary artery bypass grafting (CABG) and mitral valve surgery. The risk-adjusted relationships between mortality and clinical and hemodynamic parameters were assessed by meta-regression. A total of 62 studies (12,331 patients) were identified. Weighted average early mortality was 6.9%. Cumulative 1-year, 5-year and 10-year survival were 88.5%, 71.5% and 53.9%, respectively. Endoventricular reconstruction (EVR) showed a reduced risk for both early (RR=0.79, p<0.005) and late (RR=0.67, p<0.001) mortality compared to the linear repair (early: RR=1.38, p<0.001; late: RR=1.83, p<0.001). Early and late mortality were mainly cardiac in origin, with as predominant cause heart failure in respectively 49.7% and 34.5% of the cases. Ventricular arrhythmias caused 16.6% of early deaths and 17.2% of late deaths. Concomitant CABG significantly decreased late mortality (RR=0.28, p<0.001) without increasing early mortality (RR=1.018, p=0.858). Concomitant mitral valve surgery showed both an increased risk for early (RR=1.57, p=0.001) and late mortality (RR=4.28, p<0.001). No clinical or hemodynamic parameters were found to influence mortality. It is noteworthy that only one third of patients included in the current analysis were operated for heart failure (14 studies, 4135 patients). In this group we noted an early mortality of 11.0% with a late mortality (3-year) of 15.2%. This analysis of pooled literature data showed that LV reconstruction surgery is performed with acceptable mortality and EVR may be the preferred technique with a reduced risk for early and late mortality. Concomitant CABG improved outcome, whereas the need for mitral valve surgery appeared an index of gravity. No clinical or hemodynamic parameters were found to influence mortality; specifically LV ejection fraction and LV volumes both did not predict outcome.
- Published
- 2008
- Full Text
- View/download PDF
13. Prognostic significance of renal function in patients undergoing dobutamine stress echocardiography.
- Author
-
Karagiannis SE, Feringa HH, Elhendy A, van Domburg R, Chonchol M, Vidakovic R, Bax JJ, Karatasakis G, Athanasopoulos G, Cokkinos DV, and Poldermans D
- Subjects
- Aged, Dobutamine, Female, Heart Diseases mortality, Humans, Kidney Function Tests methods, Male, Middle Aged, Prognosis, Echocardiography, Stress, Heart Diseases diagnostic imaging, Heart Diseases physiopathology, Kidney physiopathology
- Abstract
Background: Dobutamine stress echocardiography (DSE) is used for risk stratification of patients with suspected coronary artery disease (CAD). However, the prognostic value of DSE among the entire strata of renal function has yet to be determined. We assessed the prognostic value of renal function relative to DSE findings., Methods: We studied 2292 patients, divided into 729 (32%) patients with normal renal function [creatinine clearance (CrCl) >90 ml/min] and 1563 (68%) with renal dysfunction, classified as mild (CrCl: 60-90 ml/min) in 933, moderate (CrCl: 30-60 ml/min) in 502 and severe (CrCl < 30 ml/min) in 128 patients. All patients underwent DSE for the evaluation of known or suspected CAD and were followed for a mean of 8 years., Results: New wall motion abnormalities during DSE and mildly, moderately and severely abnormal CrCl were powerful independent predictors for all-cause mortality, cardiac death and hard cardiac events (cardiac death and non-fatal myocardial infarction). Kaplan-Meier curves demonstrated that patients with normal DSE and renal dysfunction have greater probability for cardiac death and hard cardiac events compared to those with normal renal function. The warranty of a normal DSE in the presence of moderate renal dysfunction was 15 and 36 months for 10 and 20% risk for cardiac death and hard cardiac events, respectively., Conclusions: The presence and severity of renal dysfunction has additional independent prognostic value over DSE findings. The low-risk warranty period after a normal DSE is determined by the severity of renal dysfunction.
- Published
- 2008
- Full Text
- View/download PDF
14. Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery.
- Author
-
Feringa HH, Schouten O, Karagiannis SE, Brugts J, Elhendy A, Boersma E, Vidakovic R, van Sambeek MR, Noordzij PG, Bax JJ, and Poldermans D
- Subjects
- Aged, Biomarkers metabolism, Cholesterol, LDL drug effects, Cholesterol, LDL metabolism, Dose-Response Relationship, Drug, Female, Heart Rate drug effects, Humans, Male, Multivariate Analysis, Myocardial Ischemia diagnosis, Outcome Assessment, Health Care, Prospective Studies, Troponin T drug effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors administration & dosage, Myocardial Ischemia metabolism, Troponin T metabolism, Vascular Surgical Procedures
- Abstract
Objectives: This study sought to examine whether higher statin doses and lower low-density lipoprotein (LDL) cholesterol are associated with improved cardiac outcome in vascular surgery patients., Background: Statins may have cardioprotective effects during major vascular surgery., Methods: In a prospective study of 359 vascular surgery patients, statin dose and cholesterol levels were recorded preoperatively. Myocardial ischemia and heart rate variability were assessed by 72-h 12-lead electrocardiography starting 1 day before to 2 days after surgery. Troponin T was measured on postoperative day 1, 3, 7, and before discharge. Cardiac events included cardiac death or nonfatal Q-wave myocardial infarction at 30 days and follow-up (mean 2.3 years)., Results: Perioperative myocardial ischemia, troponin T release, 30-day events, and late cardiac events occurred in 29%, 23%, 4%, and 18%, respectively. In multivariate analysis, lower LDL cholesterol (per 10 mg/dl) correlated with lower myocardial ischemia (odds ratio [OR] 0.87, 95% confidence interval [CI] 0.80 to 0.95), troponin T release (OR 0.89, 95% CI 0.82 to 0.96), and 30-day (OR 0.89, 95% CI 0.78 to 1.00) and late cardiac events (hazard ratio 0.91, 95% CI 0.84 to 0.96). Higher statin doses (per 10% of maximum recommended dose) correlated with lower myocardial ischemia (OR 0.85, 95% CI 0.76 to 0.93), troponin T release (OR 0.84, 95% CI 0.76 to 0.93), and 30-day (OR 0.62, 95% CI 0.40 to 0.96) and late cardiac events (hazard ratio 0.76, 95% CI 0.65 to 0.89), even after adjusting for LDL cholesterol. Significantly higher perioperative heart rate variability was observed in patients with higher statin doses., Conclusions: Higher statin doses and lower LDL cholesterol correlate with lower perioperative myocardial ischemia, perioperative troponin T release, and 30-day and late cardiac events in major vascular surgery.
- Published
- 2007
- Full Text
- View/download PDF
15. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study.
- Author
-
Poldermans D, Schouten O, Vidakovic R, Bax JJ, Thomson IR, Hoeks SE, Feringa HH, Dunkelgrün M, de Jaegere P, Maat A, van Sambeek MR, Kertai MD, and Boersma E
- Subjects
- Aged, Exercise Test, Feasibility Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Ischemia etiology, Myocardial Ischemia surgery, Pilot Projects, Risk Factors, Treatment Outcome, Angioplasty, Balloon, Coronary, Coronary Artery Bypass, Myocardial Ischemia prevention & control, Stents, Vascular Surgical Procedures
- Abstract
Objectives: The purpose of this research was to perform a feasibility study of prophylactic coronary revascularization in patients with preoperative extensive stress-induced ischemia., Background: Prophylactic coronary revascularization in vascular surgery patients with coronary artery disease does not improve postoperative outcome. If a beneficial effect is to be expected, then at least those with extensive coronary artery disease should benefit from this strategy., Methods: One thousand eight hundred eighty patients were screened, and those with > or =3 risk factors underwent cardiac testing using dobutamine echocardiography (17-segment model) or stress nuclear imaging (6-wall model). Those with extensive stress-induced ischemia (> or =5 segments or > or =3 walls) were randomly assigned for additional revascularization. All received beta-blockers aiming at a heart rate of 60 to 65 beats/min, and antiplatelet therapy was continued during surgery. The end points were the composite of all-cause death or myocardial infarction at 30 days and during 1-year follow-up., Results: Of 430 high-risk patients, 101 (23%) showed extensive ischemia and were randomly assigned to revascularization (n = 49) or no revascularization. Coronary angiography showed 2-vessel disease in 12 (24%), 3-vessel disease in 33 (67%), and left main in 4 (8%). Two patients died after revascularization, but before operation, because of a ruptured aneurysm. Revascularization did not improve 30-day outcome; the incidence of the composite end point was 43% versus 33% (odds ratio 1.4, 95% confidence interval 0.7 to 2.8; p = 0.30). Also, no benefit during 1-year follow-up was observed after coronary revascularization (49% vs. 44%, odds ratio 1.2, 95% confidence interval 0.7 to 2.3; p = 0.48)., Conclusions: In this randomized pilot study, designed to obtain efficacy and safety estimates, preoperative coronary revascularization in high-risk patients was not associated with an improved outcome.
- Published
- 2007
- Full Text
- View/download PDF
16. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease.
- Author
-
Feringa HH, Karagiannis SE, van Waning VH, Boersma E, Schouten O, Bax JJ, and Poldermans D
- Subjects
- Aged, Brachial Artery physiopathology, Cholesterol, LDL analysis, Female, Humans, Male, Middle Aged, Multivariate Analysis, Peripheral Vascular Diseases mortality, Peripheral Vascular Diseases physiopathology, Prognosis, Prospective Studies, Regional Blood Flow, Survival Analysis, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Peripheral Vascular Diseases drug therapy
- Abstract
Background: The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are associated with improved outcome in patients with peripheral arterial disease. Statins may also have beneficial properties beyond their lipid-lowering effect., Methods: A prospective, observational cohort study was conducted at a university hospital from 1990 to 2005 to examine whether higher doses of statins and lower low-density lipoprotein (LDL) cholesterol levels are both independently associated with improved outcome in peripheral arterial disease. Enrolled were 1374 consecutive patients (age, 61 +/- 10 years, 73% male) with peripheral arterial disease (ankle-brachial index
- Published
- 2007
- Full Text
- View/download PDF
17. Myocardial viability estimation during the recovery phase of stress echocardiography after acute beta-blocker administration.
- Author
-
Karagiannis SE, Feringa HH, Bax JJ, Elhendy A, Dunkelgrun M, Vidakovic R, Hoeks SE, van Domburg R, Valhema R, Cokkinos DV, and Poldermans D
- Subjects
- Adrenergic beta-Antagonists administration & dosage, Coronary Artery Disease physiopathology, Echocardiography, Stress, Female, Heart Rate, Humans, Male, Middle Aged, Radionuclide Ventriculography, Recovery of Function, Stroke Volume, Time Factors, Tomography, Emission-Computed, Single-Photon, Adrenergic beta-Antagonists pharmacology, Coronary Artery Disease diagnostic imaging, Heart drug effects, Myocardium
- Abstract
Background: Myocardial viability assessment in severely dysfunctional segments by dobutamine stress echocardiography (DSE) is less sensitive than nuclear scanning., Aim: To assess the additional value of using the recovery phase of DSE after acute beta-blocker administration for identifying viable myocardium., Methods: The study included 49 consecutive patients with ejection fraction (LVEF)
or=4 viable segments were considered viable. Coronary revascularization followed within 3 months in all patients. Radionuclide evaluation of LVEF was performed before and 12 months after revascularization., Results: Viability with DISA-SPECT was detected in 463 (59%) segments, while 154 (19.7%) segments presented as scar. The number of viable segments increased from 415 (53%) at DSE to 463 (59%) at DSE and recovery, and the number of viable patients increased from 43 to 49 respectively. LVEF improved by >or=5% in 27 patients. Multivariate regression analysis showed that, DSE with recovery phase was the only independent predictor of >or=5% LVEF improvement after revascularization (OR 14.6, CI 1.4-133.7)., Conclusion: In this study, we demonstrate that the recovery phase of DSE has an increased sensitivity for viability estimation compared to low-high dose DSE. - Published
- 2007
- Full Text
- View/download PDF
18. Mitral valve repair and replacement in endocarditis: a systematic review of literature.
- Author
-
Feringa HH, Shaw LJ, Poldermans D, Hoeks S, van der Wall EE, Dion RA, and Bax JJ
- Subjects
- Humans, Cardiac Surgical Procedures, Endocarditis, Bacterial complications, Heart Valve Diseases microbiology, Heart Valve Diseases surgery, Heart Valve Prosthesis Implantation, Mitral Valve
- Abstract
Background: Several observational studies have suggested a superior survival after mitral valve repair compared with replacement in patients undergoing surgery for infective endocarditis. The objective of this study was to systematically review the rate of morbidity and mortality associated with mitral valve repair or replacement in infective endocarditis., Methods: A Medline search was conducted for literature and a systematic review of 24 studies, reporting prognosis of patients who underwent surgery for mitral valve endocarditis, was performed. Information on the patients, type of surgery, and follow-up was abstracted using standardized protocols., Results: A total of 470 patients (39%) underwent mitral valve repair and 724 patients (61%) underwent valve replacement. Lower in-hospital mortality (2.3% versus 14.4%, relative risk: 0.16, 95% confidence interval: 0.09 to 0.30, p < 0.0001) and long-term mortality (7.8% versus 40.5%, relative risk: 0.19, 95% confidence interval: 0.13 to 0.29, p < 0.0001) were observed among patients undergoing mitral valve repair compared with replacement. In addition, the rates of early reoperation (2.2% versus 12.7%, p < 0.0001), early cerebrovascular events (4.7% versus 11.5%, p = 0.045), late reoperation (4.7% versus 8.7%, p = 0.039), late recurrent endocarditis (1.8% versus 7.3%, p = 0.0013), and late cerebrovascular events (1.6% versus 24.4%, p < 0.0001) were significantly lower after mitral valve repair. Meta-regression analysis demonstrated that mitral valve repair over replacement was associated with a better early and late prognosis after surgery. Male sex and acute surgery were (nonsignificantly) predictive of worse early outcome., Conclusions: A systematic review of literature showed that mitral valve repair is associated with good clinical in-hospital and long-term results among patients undergoing surgery for infective endocarditis.
- Published
- 2007
- Full Text
- View/download PDF
19. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events.
- Author
-
Schouten O, van Domburg RT, Bax JJ, de Jaegere PJ, Dunkelgrun M, Feringa HH, Hoeks SE, and Poldermans D
- Subjects
- Aged, Coronary Artery Disease therapy, Death, Drug Delivery Systems, Heart Diseases etiology, Humans, Immunosuppressive Agents administration & dosage, Male, Middle Aged, Myocardial Infarction etiology, Registries, Retrospective Studies, Time Factors, Angioplasty, Balloon, Coronary, Heart Diseases mortality, Platelet Aggregation Inhibitors therapeutic use, Stents, Surgical Procedures, Operative adverse effects
- Published
- 2007
- Full Text
- View/download PDF
20. Pro: Beta-blockers are indicated for patients at risk for cardiac complications undergoing noncardiac surgery.
- Author
-
Schouten O, Bax JJ, Dunkelgrun M, Feringa HH, and Poldermans D
- Subjects
- Humans, Intraoperative Complications epidemiology, Risk Factors, Adrenergic beta-Antagonists therapeutic use, Intraoperative Complications prevention & control, Surgical Procedures, Operative adverse effects
- Published
- 2007
- Full Text
- View/download PDF
21. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
- Author
-
Feringa HH, Bax JJ, Boersma E, Kertai MD, Meij SH, Galal W, Schouten O, Thomson IR, Klootwijk P, van Sambeek MR, Klein J, and Poldermans D
- Subjects
- Adrenergic beta-Antagonists administration & dosage, Adrenergic beta-Antagonists pharmacology, Aged, Biomarkers, Cohort Studies, Dose-Response Relationship, Drug, Echocardiography, Stress, Elective Surgical Procedures, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Monitoring, Physiologic, Myocardial Ischemia blood, Myocardial Ischemia epidemiology, Postoperative Care, Postoperative Complications blood, Postoperative Complications mortality, Postoperative Period, Preoperative Care, Proportional Hazards Models, Risk, Adrenergic beta-Antagonists therapeutic use, Heart Rate drug effects, Myocardial Ischemia prevention & control, Postoperative Complications prevention & control, Troponin T blood, Vascular Surgical Procedures statistics & numerical data
- Abstract
Background: Adverse perioperative cardiac events occur frequently despite the use of beta (beta)-blockers. We examined whether higher doses of beta-blockers and tight heart rate control were associated with reduced perioperative myocardial ischemia and troponin T release and improved long-term outcome., Methods and Results: In an observational cohort study, 272 vascular surgery patients were preoperatively screened for cardiac risk factors and beta-blocker dose. Beta-blocker dose was converted to a percentage of maximum recommended therapeutic dose. Heart rate and ischemic episodes were recorded by continuous 12-lead electrocardiography, starting 1 day before to 2 days after surgery. Serial troponin T levels were measured after surgery. All-cause mortality was noted during follow-up. Myocardial ischemia was detected in 85 of 272 (31%) patients and troponin T release in 44 of 272 (16.2%). Long-term mortality occurred in 66 of 272 (24.2%) patients. In multivariate analysis, higher beta-blocker doses (per 10% increase) were significantly associated with a lower incidence of myocardial ischemia (hazard ratio [HR], 0.62; 95% confidence interval [CI], 0.51 to 0.75), troponin T release (HR, 0.63; 95% CI, 0.49 to 0.80), and long-term mortality (HR, 0.86; 95% CI, 0.76 to 0.97). Higher heart rates during electrocardiographic monitoring (per 10-bpm increase) were significantly associated with an increased incidence of myocardial ischemia (HR, 2.49; 95% CI, 1.79 to 3.48), troponin T release (HR, 1.53; 95% CI, 1.16 to 2.03), and long-term mortality (HR, 1.42; 95% CI, 1.14 to 1.76)., Conclusions: This study showed that higher doses of beta-blockers and tight heart rate control are associated with reduced perioperative myocardial ischemia and troponin T release and improved long-term outcome in vascular surgery patients.
- Published
- 2006
- Full Text
- View/download PDF
22. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease.
- Author
-
Feringa HH, van Waning VH, Bax JJ, Elhendy A, Boersma E, Schouten O, Galal W, Vidakovic RV, Tangelder MJ, and Poldermans D
- Subjects
- Female, Humans, Male, Middle Aged, Prospective Studies, Survival Rate, Time Factors, Atherosclerosis drug therapy, Atherosclerosis mortality, Peripheral Vascular Diseases drug therapy, Peripheral Vascular Diseases mortality, Protective Agents therapeutic use
- Abstract
Objectives: We sought to investigate the effect of cardiac medication on long-term mortality in patients with peripheral arterial disease (PAD)., Background: Peripheral arterial disease is associated with increased cardiovascular morbidity and mortality. Treatment guidelines recommend aggressive management of risk factors and lifestyle modifications. However, the potential benefit of cardiac medication in patients with PAD remains ill defined., Methods: In this prospective observational cohort study, 2,420 consecutive patients (age, 64 +/- 11 years, 72% men) with PAD (ankle-brachial index < or =0.90) were screened for clinical risk factors and cardiac medication. Follow-up end point was death from any cause. Propensity scores for statins, beta-blockers, aspirin, angiotensin-converting enzyme (ACE) inhibitors, calcium channel blockers, diuretics, nitrates, coumarins, and digoxin were calculated. Cox regression models were used to analyze the relation between cardiac medication and long-term mortality., Results: Medical history included diabetes mellitus in 436 patients (18%), hypercholesterolemia in 581 (24%), smoking in 837 (35%), hypertension in 1,162 (48%), coronary artery disease in 1,065 (44%), and a history of heart failure in 214 (9%). Mean ankle-brachial index was 0.58 (+/-0.18). During a median follow-up of eight years, 1,067 patients (44%) died. After adjustment for risk factors and propensity scores, statins (hazard ratio [HR] 0.46, 95% confidence interval [CI] 0.36 to 0.58), beta-blockers (HR 0.68, 95% CI 0.58 to 0.80), aspirins (HR 0.72, 95% CI 0.61 to 0.84), and ACE inhibitors (HR 0.80, 95% CI 0.69 to 0.94) were significantly associated with a reduced risk of long-term mortality., Conclusions: On the basis of this observational longitudinal study, statins, beta-blockers, aspirins, and ACE inhibitors are associated with a reduction in long-term mortality in patients with PAD.
- Published
- 2006
- Full Text
- View/download PDF
23. Outcome after mitral valve repair for acute and healed infective endocarditis.
- Author
-
Feringa HH, Bax JJ, Klein P, Klautz RJ, Braun J, van der Wall EE, Poldermans D, and Dion RA
- Subjects
- Acute Disease, Adult, Aged, Anti-Bacterial Agents therapeutic use, Combined Modality Therapy, Endocarditis, Bacterial drug therapy, Feasibility Studies, Female, Heart Valve Diseases drug therapy, Humans, Male, Middle Aged, Mitral Valve diagnostic imaging, Mitral Valve Insufficiency surgery, Prognosis, Reoperation, Treatment Outcome, Ultrasonography, Endocarditis, Bacterial surgery, Heart Valve Diseases surgery, Mitral Valve surgery
- Abstract
Objective: To evaluate the long-term clinical and echocardiographic outcomes after mitral valve surgery for acute and healed infective endocarditis., Methods: Of 37 consecutive patients presenting with native mitral valve endocarditis, mitral valve repair (MVRep) was feasible in 34 (92%) patients. In 17 (50%) patients, surgery was indicated during antibiotic therapy (acute endocarditis), whereas 17 (50%) underwent surgery after antibiotic therapy was completed (healed endocarditis). Patients were evaluated for early and long-term clinical and echocardiographic outcome., Results: In-hospital death occurred in two (6%) patients and two (6%) died during follow-up, with a 2-year survival of 100% in healed endocarditis as compared to 76% (p=0.03) in patients undergoing surgery in acute endocarditis. No patient with acute endocarditis needed repeat mitral valve surgery. Three (9%) patients underwent re-operation because of early mitral regurgitation (n=1) or late recurrent endocarditis (n=2). The average grade of mitral regurgitation was 3.8+/-0.4 (all grades 3 to 4+) before surgery and 0.6+/-0.8 during follow-up (p<0.001). Significant reductions in left atrial (from 52+/-8mm to 46+/-8mm, p=0.004), left ventricular end-diastolic (from 61+/-8mm to 54+/-8mm, p=0.001), and end-systolic dimensions (from 41+/-8mm to 36+/-9 mm, p=0.02) were observed during follow-up, compared to preoperative dimensions. Of note, significant reverse remodeling was only observed in patients undergoing surgery in healed endocarditis., Conclusion: MVRep for mitral valve endocarditis is feasible with good clinical results, maintained valve competency with significant reductions in left atrial and left ventricular dimensions after surgery.
- Published
- 2006
- Full Text
- View/download PDF
24. Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging.
- Author
-
Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Huurman A, Feringa HH, and Poldermans D
- Subjects
- Adult, Aged, Angina Pectoris mortality, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease pathology, Disease-Free Survival, Female, Humans, Male, Middle Aged, Multivariate Analysis, Perfusion, Prognosis, Proportional Hazards Models, Risk, Risk Factors, Time Factors, Angina Pectoris diagnostic imaging, Angina Pectoris pathology, Organophosphorus Compounds pharmacology, Organotechnetium Compounds pharmacology, Radiopharmaceuticals pharmacology, Tomography, Emission-Computed, Single-Photon methods
- Abstract
Unlabelled: Angina pectoris is a major symptom associated with myocardial ischemia. The aim of this study was to find whether stress myocardial perfusion imaging can independently predict mortality in patients with angina., Methods: We studied 455 patients with stable angina pectoris by exercise or dobutamine stress (99m)Tc-tetrofosmin myocardial perfusion tomographic imaging. An abnormal finding was defined as a reversible or fixed perfusion abnormality. The endpoint during follow-up was death from any cause., Results: Mean age was 60+/-10 y. There were 266 men (58% of the patients). Myocardial perfusion was normal in 137 patients (30%). Perfusion abnormalities were reversible in 167 patients and fixed in 151 patients. During a mean follow-up of 6+/-1.7 y, 93 patients (20%) died. The annual mortality rate was 1.5% in patients with normal perfusion and 4.5% in patients with abnormal perfusion. Patients with a multivessel distribution of perfusion abnormalities had a higher annual death rate than patients with abnormalities in a single-vessel distribution (5.1% vs. 3.7%). In a multivariate analysis model, independent predictors of death were age (risk ratio, 1.05; 95% confidence interval [CI], 1.03-1.08), the male sex (risk ratio, 2.1; CI, 1.3-3.4), diabetes (risk ratio, 2.2; CI, 1.4-3.5), heart failure (risk ratio, 2.7; CI, 1.6-4.5), smoking (risk ratio, 1.7; CI, 1.1-2.6), reversible perfusion abnormalities (risk ratio, 1.9; CI, 1.1-2.8), and fixed perfusion abnormalities (risk ratio, 2; CI, 1.2-3.1)., Conclusion: Stress 99mTc-tetrofosmin myocardial perfusion imaging provides independent information for predicting mortality in patients with stable angina pectoris. Both reversible and fixed defects are associated with an increased risk of death. The extent of stress perfusion abnormalities is a major determinant of mortality. Patients with normal perfusion have a low mortality rate during long-term follow-up.
- Published
- 2005
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.